Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap3.90B
Enterprise Value3.67B
Trailing P/E10.39
Forward P/E6.26
ACAD
(NASDAQ)ACADIA Pharmaceuticals Inc.
$22.60-- (--)
Loading... - Market loading
ACADIA Pharmaceuticals (ACAD) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)3.56
Forward Price/Sales3.24
Price/Book (mrq)3.13
Price/Tangible Book (mrq)3.42
Price/FCF (ttm)34.36
Price/OCF (ttm)31.61
PEG Ratio0.16
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue3.35
EV/Earnings9.77
EV/EBITDA31.10
EV/EBIT35.03
EV/FCF32.32
Stock Price
Current price, 52-week range, and moving averages
Current Price$22.60
1-Day Change2.31%
52-Week High$28.35
52-Week Low$19.69
52-Week Change0.53%
YTD Change-14.04%
1-Year Change0.85%
50-Day MA$21.71
200-Day MA$23.26
Avg Volume (30 day)1.40M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding172.71M
Book Value per Share$7.23
Net Cash per Share$1.34
FCF per Share$0.66
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$31.60
Target Upside/Downside39.82%
Analyst ConsensusBuy
Analyst Count12
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin91.47%
EBITDA Margin (ttm)10.78%
EBIT Margin (ttm)9.57%
Operating Margin (ttm)7.39%
Pretax Margin (ttm)10.51%
Profit Margin (ttm)34.30%
FCF Margin (ttm)10.37%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)30.10%
Return on Assets (ttm)23.40%
Return on Invested Capital (ttm)10.31%
Return on Capital Employed (ttm)8.06%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue1.10B
Gross Profit1.00B
Operating Income80.91M
Pretax Income115.11M
Net Income375.65M
EBITDA118.07M
EBIT104.81M
Diluted EPS$2.20
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow123.49M
Capital Expenditures9.90M
Free Cash Flow113.59M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth9.93%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)1.61B
Cash & Securities (mrq)282.21M
Net Cash (mrq)231.42M
Net Cash per Share$1.34
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)50.79M
Working Capital (mrq)790.49M
Total Equity (mrq)1.25B
Book Value per Share$7.23
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)3.59
Quick Ratio (mrq)3.48
Debt/Equity (mrq)0.04
Debt/EBITDA (ttm)0.43
Debt/FCF (ttm)0.45
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield9.62%
FCF Yield2.91%
Buyback Yield-1.34%
Total Shareholder Yield-1.34%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score3.66
Piotroski F-Score6/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Lynch Fair Value$142.78
Lynch Upside/Downside531.76%
Graham Number$18.91
Graham Upside/Downside-16.34%
Frequently Asked Questions About ACADIA Pharmaceuticals Statistics
What are the key financial metrics for ACAD?
ACADIA Pharmaceuticals Inc. (ACAD) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is ACAD's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether ACADIA Pharmaceuticals is overvalued or undervalued.
How do I read ACAD's profitability ratios?
ACADIA Pharmaceuticals's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do ACAD's debt ratios indicate?
The financial health section shows ACADIA Pharmaceuticals's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is ACAD's dividend analysis?
The dividend section covers ACADIA Pharmaceuticals's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.